View Older Stories View More Recent Stories
-
Citi on U.S. Major Pharmaceuticals: 2Q10 Outperformance Expected
-
Citi Reiterates a 'Hold' on Pfizer (PFE), More Pain, No Gain; Removing Tanezumab from Estimates
-
Citi 2010 Healthcare Conference Key Takeaways - MRK, PFE, BMY, ISIS, NPSP, & MYGN
-
Goldman Sachs' Hedge Fund VIP List (CIT, CF, ACL, GILD, more...)
-
Notable Analyst Rating Changes 05/21: CCL, MA, CAP, KEY Upgraded; BRCD, WEN, OEH, DRI Downgraded
-
Citi Reiterates a 'Buy' on Teva & Watson Pharma After Canadian Approval of Generic Lipitor
-
Tepper's Appaloosa Cuts Stakes In Bank Stocks (BAC, C, WFC), Enters Pharmaceutical and Energy Stocks
-
Citi Issues Q1 Preview on U.S. Major Pharmaceuticals; Merck (MRK) Remains 'Top Pick'
-
Notable Analyst Rating Changes 04/08: ABC, EOG, BMC Upgraded; CML, EBAY, KEY, ELX, QLGC Downgraded
-
Rosenstein's Jana Partners Q4 13F Breakdown: Ups Bets In Financials
-
Loeb's Third Point Q4 13F Breakdown: Ups Bets In Financials, Exits Large Pharma
-
John Paulson's Paulson & Co Q4 13F Breakdown: Greatly Expands Positions in Banks, Remains Heavy In Gold
-
Goldman Sachs Removed Abbott Labs (ABT) From Buy List, Eli Lilly (LLY) From Sell List
-
Active equity option families in first 30 minutes of trading according to Track Data are: BAC C PFE YHOO
-
Notable Analyst Rating Changes 10/19: AXP, NOV, EL, DKS Upgrade; FNM/FRE, ANF, MAT, LUV Downgrade
-
David Moenning’s Daily State of the Markets: 7/22
-
Elan (ELN) Up On Renewed Takeover Talk
-
Morning Movers 5/18: KONA, AHR, IDMI, LGTY, IBN, HEB Higher; SPIR, COIN, BIDZ, AYE Lower
-
David Moenning's Daily State of the Markets: 4/28
-
Morning Movers 3/12: CV Therapeutics (CVTX) Surges On Buyout, GE (GE) Up On Rating Cut/Stable Outlook
-
Notable Analyst Rating Changes 3/5: BIDU, T, ADBE, SIGM Upgraded; CXR, RIO, GPS Downgraded
-
David Moenning's Daily State of the Markets: 2/9
-
Notable Analyst Rating Changes 2/9: WYE, PFE, ADBE, CHK, GLW, BIG Upgraded; LEN, PAS, CVX, DOW Downgraded
-
UBS Upgrades Pfizer (PFE) to Buy
-
Credit Suisse Upgrades Pfizer (PFE) to Outperform
-
Top 10 News Items 1/26-1/30: 'Bad Bank' Plan Boosts Stocks, But Gains Reversed on Reports of a Snag; $819 Stimulus Package Passed; Pfizer Confirms Wyeth Bid
-
Morning Movers 1/26: Barclays plc (BCS) Up After Easing Concerns; Rohm and Haas (ROH) Slammed As Dow Walks
-
Top 10 News Items: 1/19-1/23: European Banking Fears Spread to US; Microsoft Surprises the Street with a Miss; Merrill's Thain Spends a Million on His Office
-
Notable Analyst Rating Changes 1/12: CFR, PALM, PFE Upgraded; AA, HOG, MDAS, BNI Downgraded
-
Citi Reiterates a 'Hold' on Pfizer (PFE), M&A Needed to Reposition the Company
-
Citi Issues List of 50 Highest Dividend Yield Stocks (MIC, FLY, AYR, GCI, OMX, STI, More...)
-
Morning Movers 10/21: Texas Instruments (TXN) Lower on Results/Guidance, 3M (MMM) Higher
-
David Moenning's Daily State of the Markets: 10/20
-
Notable Analyst Rating Changes 10/20: KFT, RIG, BBY, PFE, YGE Upgraded; DE, INTC, MET, POZN Downgraded
-
David Moenning's Daily State of the Markets: 10/08
-
Active Equity option families in first 30-minutes of Trading: C WB NCC GE PFE
-
David Moenning's Daily State of the Markets: 7/23
-
Citi Initiates Coverage on Pfizer (PFE) with a Hold
-
David Moenning's Daily State of the Markets: 4/17
-
Pre-Open Movers 4/17: FUQI Intl (FUQI) Higher on Raised Guidance, Nokia (NOK) Lower on Results/Outlook
-
David Moenning's Daily State of the Markets: 1/23

